Peter Kramer, author of Listening to Prozac and Against Depression, hosts the award-winning The Infinite Mind, a PBS radio show focusing on the latest developments in neuro-psychology , mental illness and wellness, and alternatives to achieving and sustaining brain health Copies of previous shows can be downloaded from the website (Check here for downloads). IM may air on a PBS station in your area. If not, here’s the Sirius schedule.
From the website: ”
Recent programs include: Depression in the Brain, Dyslexia, Asperger’s Syndrome (a two-part special report), ECT, Bipolar Disorder, Multiple Sclerosis, Mental Health Care for Immigrants, Seasonal Affective Disorder, Alcoholism, Schizoaffective Disorder, Mental Health Care for Latinos, Pregnancy and the Mind, Epilepsy, and Mental Health and Primary Care. In the wake of the September 11 th attacks and Hurricane Katrina, the program also extensively covered subjects related to trauma, PTSD, and resilience. Among the topics to be examined in the coming year are Neuroethics and the Law, Childhood Disorders, Brain Trauma and its Prevention and Treatment, Alzheimer’s Revisited, Memory, How Boys and Girls Learn, and New Treatments for Depression.
The program “explores exciting scientific discoveries and cultural phenomena “featuring discussions with renowned neuroscientists, clinicans, public figures and clinicians, call ins, first person stories,readings and musical performances.
The Infinite Mind and other works by LCMedia have received more than 60 major broadcast awards, including: a Guggenheim Fellowship, a United Nations Media Award, a Peabody Award, six National Headliner Awards, eight International Radio Awards, four Gracie Awards, and five Unity Awards in Media for coverage of minority issues. Media awards received from leading mental health organizations include: the American College of Neuropsychopharmacology, the National Institute of Mental Health, four awards from the National Mental Health Association, the National Alliance on Mental Illness, the American Psychiatric Association, and the National Alliance for Research on Schizophrenia and Depression.